Bristol Myers Squibb Company

Director, Immunology Strategy- Worldwide Commercial, Rheumatology and Dermatology

Location
Princeton, NJ, United States
Posted
Aug 29, 2020
Ref
R1519277
Required Education
Bachelors Degree
Position Type
Full time
Bristol-Myers Squibb is a global Biopharma company committed to a single mission: to discover, develop, and deliver innovative medicines focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis.

Join us and make a difference. We hire the best people and provide them with a work environment that places a premium on diversity, integrity, collaboration and personal development. Through a culture of inclusion, we create a better, more productive work environment. We believe that the diverse experiences and perspectives of all our employees help to drive innovation and transformative business results.

The successful candidate will be responsible for understanding the competitive environment, treatment landscape, pricing and access dynamics, and have a passion for understanding the science underlying immune-mediated diseases in the areas of Rheumatology and Dermatology. An ability to translate the data, trends and anticipate the future market place opportunities, what it will take to win, and help formulate how BMS can achieve this is key for the individual in this role. This individual will partner with R&D teams in Discovery, Early and Late stage development, Business Development, Value Access & Pricing, Business Insights and Analytics, and other commercial colleagues on specific asset and brand teams to inform and formulate the enterprise disease area strategies in the therapeutic areas of responsibility. This individual will play a key role in helping the organization make assessments around the long-term financial plan and prioritization of the portfolio and investment decisions to shape the strategy in these therapeutic areas.

Specific responsibilities include:
  • Leading and setting the vision for our ambition in Rheumatology and Dermatology and engaging the matrix team on that vision
  • Leading cross-functional workstreams and collaboration with discovery/development/asset/brand teams to develop disease/therapeutic area strategies in Rheumatology and Dermatology, and driving strategic initiatives which may include:
    • Technology landscape, benchmarking, and strategic assessments
    • Competitive analysis, market analysis, clinical assessments for scenario planning associated with Rheumatology and Dermatology specialties, diseases, and portfolio-level dynamics
    • Identification and evaluation of cross-therapeutic area investment strategies in preparation for executive-level management and governance evaluation
    • Rapid impact assessments of key market and/or BMS portfolio events in the disease landscape, with both a franchise and market lens
  • Supporting enterprise-level strategic planning in preparation for the annual Leadership Team and Board of Directors meeting via close collaboration with R&D, commercial, BI&A and Finance stakeholders
  • Partnering with asset/brand teams on the annual brand planning process for assets within disease areas of responsibilities to ensure cohesiveness in planning and investments across the franchise at a worldwide and key market level, and ensuring efficiencies are realized.
  • Building a long-term view of the market evolution and identifying opportunities for potential new technologies and platforms that will support BMS as a future leader in Rheumatology and Dermatology
  • Providing guidance and commercialization requirements for future portfolio in disease areas (e.g., maintaining Target Opportunity Profiles (TOPs), technology gaps, including combination regimens and biomarkers/diagnostics) within therapeutic areas of responsibility
  • Maintaining an integrated and up-to-date view of diseases of interest within the Rheumatology and Dermatology landscape to support the markets
  • Assisting in development of presentations for senior management relating to the annual strategic planning and budget processes as well as on-going business updates
  • Partnering seamlessly with worldwide commercial, early asset teams, medical, finance, BI&A functions, and the markets to ensure appropriate alignment with all key portfolio initiatives and priorities


Bristol-Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees the resources to pursue their goals, both at work and in their personal lives.